icon-folder.gif   Conference Reports for NATAP  
  64rd Annual Meeting of the
American Association for the
Study of Liver Diseases
Washington, DC Nov 1-5 2013
Back grey_arrow_rt.gif
Sofosbuvir Selects the NS5B S282T Mutation In Vitro in Genotype 1-6 Replicons and Is Not Cross-Resistant to Resistance-Associated Variants Selected by Other Classes of Antiviral Inhibitors
  Reported by Jules Levin
AASLD 2013 Nov 1-4 Wash DC
Simin Xu, Sonal Rajyaguru, Sophia Chiu, Christy Hebner, Evguenia S. Svarovskaia, Viktoria Gontcharova, Brian Doehle, Michael D. Miller, Hongmei Mo Gilead Sciences, Inc., Foster City, CA
AASLD: No Resistance Detected in Four Phase 3 Clinical Studies in HCV Genotypes 1-6 of Sofosbuvir + Ribavirin With or Without Peginterferon - (11/07/13)